A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study

David Bender, Michael W. Sill, Heather A. Lankes, Henry D. Reyes, Christopher J. Darus, James E. Delmore, Jacob Rotmensch, Heidi J. Gray, Robert S. Mannel, Jeanne M. Schilder, Mark I. Hunter, Carolyn K. McCourt, Megan I. Samuelson, Kimberly K. Leslie

Research output: Contribution to journalArticle

28 Scopus citations

Fingerprint Dive into the research topics of 'A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences